Skip to main content
ADapa98-Plus
TabletSGLT2 InhibitorsOral
🇮🇳IndiaTablet

ADapa98-Plus

Generic Formulation: Dapagliflozin

Regulatory Registrant: MSD India

OralSGLT2 Inhibitors

Pricing & Therapeutic Cost Guide

MRP

387.05

10 tablets (per strip)

Indications & Usage

For the treatment of hypertension, heart failure, and diabetic nephropathy. Also used for prevention of stroke and myocardial infarction.

Warnings & Precautions

May cause angioedema. Monitor renal function and potassium levels. Avoid during pregnancy.

Side Effects

May include dry cough, hypotension, dizziness, hyperkalemia, and angioedema (rare).

Drug Interactions

May interact with potassium supplements, NSAIDs, diuretics, and lithium.

Storage & Handling

Store at room temperature. Keep container tightly closed.